Healthcare
Terra Firma buys Four Seasons for £825m
Terra Firma has acquired British elderly and specialist care provider Four Seasons for ТЃ825m.
Reiten & Co exits Ellipse Klinikken
Reiten & Co Capital Partners has exited cosmetic treatments provider Ellipse Klinikken to Swedish private clinic chain Akademikliniken.
IMI Fondi Chiusi backs Svas Biosana
IMI Fondi Chiusi has invested €6m in exchange for a minority stake in Italian medical devices and infusion solutions company Svas Biosana.
HgCapital's Voyage Care acquires Solor Care
HgCapital and SL Capital Partners portfolio company Voyage Care has acquired UK care provider Solor Care from Barclays Ventures and RBS.
August Equity's Enara makes four add-on acquisitions
August Equity's care business Enara has acquired four care providers to strengthen its position in Wales and Southern England, in a transaction valued at less than ТЃ25m.
HTGF backs KonTEM
High-Tech Gründerfonds (HTGF) has made an investment in German healthcare technology start-up KonTEM GmbH.
HTGF at al. provide seed funding for Oncgnostics
High-Tech Gründerfonds (HTGF) has invested €500,000 in a seed round for molecular diagnostic start-up Oncgnostics GmbH.
Seventure leads €3.5m round in LNC
Seventure Partners has led a €3.5m funding round for French medical nutrition specialist Laboratoires Nutrition et Cardiométabolisme (LNC), alongside a pool of new investors and historical backer EPI.
Novo and Almi in SEK 25.5m round for Denator
Novo Seeds and Almi Invest have participated in a SEK 25.5m financing round for Swedish biotech company Denator.
August Equity's Active Assistance Group buys Communicare
August Equity's portfolio company Active Assistance has acquired British care service provider Communicare.
Celtic Therapeutics sets up $50m antibody drug company
Celtic Therapeutics has launched an Antibody-Drug-Conjugate (ADC) business, Switzerland-based ADC Therapeutics, with $50m of capital.
Sofinnova Partners lists DBV
Paris-based Sofinnova Partners has listed DBV Technologies, raising €40.5m in the IPO on NYSE Euronext Paris.
Sambrinvest joins €23.6m series-B round in bioscience
Sambrinvest has joined Mitsui Global Investment, Shire, ATMI and the Boehringer Ingelheim Venture Fund to invest €17m in Belgian cell therapy company Promethera Biosciences. The Walloon region has granted a further €6.6m in the form of a loan.
Ashridge back special needs care provider Phoenix
Ashridge Capital has invested ТЃ3.5m in a management buyout of special needs care provider Phoenix Learning and Care.
Imperial Innovations leads £3m funding round in Abingdon Health
Imperial Innovations Group has led a ТЃ3m funding round in Abingdon Health, a specialist medical diagnostics company, alongside other private investors.
Seventure and Lundbeckfond inject €5m in Enterome
Seventure Partners and Lundbeckfond Ventures have provided French biotech company Enterome with a €5m series-A round of funding.
HTGF invests in hepatitis drug project
High-Tech Gründerfonds and Russian Government-backed Maxwell Biotech Venture Fund have invested in a joint project to develop a drug aimed at the treatment of chronic hepatitis B and D.
venBio leads CHF 37m funding round for Cytos
An international syndicate of investors comprised of venBio, Amgen, Aisling Capital and Abingworth has invested up to CHF 37m in equity and debt in Swiss biotech company Cytos Biotechnology Ltd.
Index Ventures closes life sciences fund at €150m
Index Ventures has closed its latest life sciences fund, raising тЌ150m from LPs and pharmaceutical companies.
MMC Ventures announces second venture capital fund
MMC Ventures launches its second venture capital fund for young investors. The MMC Growth Generation Fund is available to investors aged 18-35 with ТЃ2,500 to ТЃ10,000 to invest.
Duke Street considers Biomnis exit
Mid-market GP Duke Street has appointed Crédit Suisse to review options - including a potential sale - for French medical analysis business Biomnis, according to a spokesperson.
Invercaria and la Caixa back nLife
Invercaria and la Caixa have invested €5m in Granada-based nanomedicine company nLife Therapeutics in exchange for a minority stake.
Montezemolo acquires Bellco
Montezemolo & Partners SGR has acquired biomedical company Bellco from Argos Soditic and MPVenture.
Apposite reaps 45% IRR on SureCalm exit
Specialist healthcare investor Apposite Capital has sold homecare services provider SureCalm Healthcare to medical technologies developer Amcare Ltd, reaping a 45% IRR.